...
机译:人体NK细胞制造的优化:全自动分离,使用IL-21改进了具有自体进纸细胞的IL-21,以及产生抗CD123-CAR-CAR-CARECHER细胞的产生
Institute for Cellular Therapeutics GMPDU IFB-Tx Hannover Medical School Hannover Germany;
Institute for Cellular Therapeutics GMPDU IFB-Tx Hannover Medical School Hannover Germany;
Institute of Experimental Hematology Hannover Medical School Hannover Germany;
Institute of Experimental Hematology Hannover Medical School Hannover Germany;
Institute for Cellular Therapeutics GMPDU IFB-Tx Hannover Medical School Hannover Germany;
Miltenyi Biotec GmbH Bergisch Gladbach Germany;
Miltenyi Biotec GmbH Bergisch Gladbach Germany;
Institute for Cellular Therapeutics GMPDU IFB-Tx Hannover Medical School Hannover Germany;
Institute for Cellular Therapeutics GMPDU IFB-Tx Hannover Medical School Hannover Germany;
Miltenyi Biotec GmbH Bergisch Gladbach Germany;
Institute of Experimental Hematology Hannover Medical School Hannover Germany;
Institute for Cellular Therapeutics GMPDU IFB-Tx Hannover Medical School Hannover Germany;
interleukin-3 receptor subunit alpha (CD123); acute myeloid leukemia; closed GMP-compliant Prodigy system; autologous feeder cells; chimeric antigen receptor-modified NK cells; IL-21;
机译:人体NK细胞制造的优化:全自动分离,使用IL-21改进了具有自体进纸细胞的IL-21,以及产生抗CD123-CAR-CAR-CARECHER细胞的产生
机译:IL-21体外扩增对人NK细胞的多重作用
机译:发育自动分离,膨胀和质量控制方案,用于临床规模制造原发性人NK细胞和字母类动物嵌合抗原受体工程
机译:来自人脐带的间充质干细胞饲养层,用于离体扩增造血干细胞
机译:ADAM10是B细胞发育,抗体产生和髓样来源的抑制细胞扩增的关键调节剂:B细胞特异性ADAM10在体内的缺失和过表达的影响。
机译:来自CD3 / CD19耗尽移植物的IL-15和IL-21的协同用途改善了对神经母细胞瘤的前体内膨胀和细胞毒性潜力:优化免疫疗法后寄生术后干细胞移植的透视
机译:高效的IL-21和饲养细胞驱动的人NK细胞的exvivo膨胀,具有在黑发瘤的异种移植小鼠模型中的治疗活性